DVA
Davita Inc
NYSE · Health Care
$140.83
-8.39 (-5.62%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 10.37B | 10.03B | 4.58B | 4.76B | 4.10B |
| Net Income | 757.45M | 659.80M | 603.43M | 585.68M | 437.36M |
| EPS | — | — | — | — | — |
| Profit Margin | 7.3% | 6.9% | 13.2% | 12.3% | 10.7% |
| Rev Growth | +3.3% | +3.3% | +19.4% | +12.6% | +5.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 4.91B | 4.91B | 3.15B | 3.36B | 3.21B |
| Total Equity | 62.93M | 62.93M | 3.64B | 3.67B | 3.22B |
| D/E Ratio | 77.99 | 77.99 | 0.87 | 0.92 | 1.00 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 2.18B | 2.01B | 1.03B | 1.00B | 923.17M |
| Free Cash Flow | — | — | 523.11M | 769.99M | 493.33M |